Show Notes
Patients say prescribed treatment can vary when it comes to two of the most widely experienced effects of menopause, vasomotor (hot flushes) and genitourinary symptoms. New guidelines for clinicians will clarify when to use hormone therapy over other medicines, and what options are available for those with a history of breast cancer. Guest/s Dr Catriona Melville, specialist gynaecologist and sub-specialist in sexual and reproductive health and Guideline Development Group Chair, Royal Australian and New Zealand College of Obstetricians and Gynaecologists References RANZCOG Management of vasomotor and genitourinary symptoms of menopause clinical guideline ABC News: Australia has new guidelines for managing menopausal symptoms
More from Health Report - Separate stories podcast
In the news: A report in the Lancet outlines the biggest risks to human health worldwide with obesity topping the list. But there are some more surprising risks identified. The TGA has approved a broader scope of use of a medicine for medical abortion care and miscarriage. A study has quantified the baseline prevalence of low testosterone in the United States military, ahead of the planned annual screening of men over the age of 30. References The Lancet: 21st century global threats to health are not what you think TGA: MS-2 Step (mifepristone and misoprostol) Testosterone Screening Thresholds in Active-Duty US Male Service Members
The first ever report from the Australian Institute of Health and Welfare that quantifies these injuries was released this week. It shows what many clinicians are already seeing in emergency rooms and surgeries. So what can be done to reduce the impact of these e-devices? Guest/s Professor Martin Wullschleger, Director of Trauma, Gold Coast Health and chair of RACS Queensland Trauma Committee References E-scooter and e-bike injuries and deaths in Australia: national trends and data limitations
A new study shows people who survive cancer have a build up of plaque in their arteries, and a higher risk of heart disease. The treatments that are used for their cancer are thought to be the cause. So what can be done to manage these new health risks? Guest/s Dr Cheng Hwee Soh, Honorary Senior Fellow at the Baker Department of Cardiometabolic Health, University of Melbourne and Group Leader, Imaging Research laboratory, Baker Institute References Coronary Plaque Burden and Plaque Composition in Long-Term Cancer Survivors: A Comparative CCTA Study
In hospital regular medications are sometimes paused while the patient recovers from other illnesses and procedures. But a new study about discontinuation of diabetes medication shows it is not reintroduced quickly once the person is discharged. Could better information transfer facilitated by a hospital pharmacist help prevent this? Guest/s Dr Tamara Milder, endocrinologist and Researcher, Medicines Intelligence Research Program, UNSW References Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes
A look at some of the Health Report correspondence this week. You can email us at [email protected]